Cargando…

Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report

We present a case report of a 26-year-old female patient with acute visual impairment, who had been treated with 50 mg/day topiramate for 5 days for migraine prophylaxis. Ocular examination showed bilateral anterior chamber narrowing and macular striae. She had no previous ocular pathology, but her...

Descripción completa

Detalles Bibliográficos
Autor principal: Dogan, Levent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874252/
https://www.ncbi.nlm.nih.gov/pubmed/35265806
http://dx.doi.org/10.14744/bej.2021.92905
_version_ 1784657640922546176
author Dogan, Levent
author_facet Dogan, Levent
author_sort Dogan, Levent
collection PubMed
description We present a case report of a 26-year-old female patient with acute visual impairment, who had been treated with 50 mg/day topiramate for 5 days for migraine prophylaxis. Ocular examination showed bilateral anterior chamber narrowing and macular striae. She had no previous ocular pathology, but her cycloplegic refraction showed a myopic shift of about 6 D. Topiramate was stopped and the patient’s unaided visual level and macular stria returned to normal with topical steroid and cyclopentolate treatment. Recognition of this side effect and discontinuation of the causative drug may prevent angle closure and related vision loss.
format Online
Article
Text
id pubmed-8874252
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-88742522022-03-08 Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report Dogan, Levent Beyoglu Eye J Case Report We present a case report of a 26-year-old female patient with acute visual impairment, who had been treated with 50 mg/day topiramate for 5 days for migraine prophylaxis. Ocular examination showed bilateral anterior chamber narrowing and macular striae. She had no previous ocular pathology, but her cycloplegic refraction showed a myopic shift of about 6 D. Topiramate was stopped and the patient’s unaided visual level and macular stria returned to normal with topical steroid and cyclopentolate treatment. Recognition of this side effect and discontinuation of the causative drug may prevent angle closure and related vision loss. Kare Publishing 2022-02-18 /pmc/articles/PMC8874252/ /pubmed/35265806 http://dx.doi.org/10.14744/bej.2021.92905 Text en Copyright: © 2022 by Beyoglu Eye Training and Research Hospital https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Case Report
Dogan, Levent
Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report
title Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report
title_full Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report
title_fullStr Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report
title_full_unstemmed Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report
title_short Acute Myopic Shift and Internal Limiting Membrane Folds Linked to Topiramate Use: A Case Report
title_sort acute myopic shift and internal limiting membrane folds linked to topiramate use: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874252/
https://www.ncbi.nlm.nih.gov/pubmed/35265806
http://dx.doi.org/10.14744/bej.2021.92905
work_keys_str_mv AT doganlevent acutemyopicshiftandinternallimitingmembranefoldslinkedtotopiramateuseacasereport